Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

The REBALANCE Study - a Prospective, Multicenter, Randomized, Pivotal Study of the May Health System

NCT: NCT06206746 · RECRUITING

NCT IDNCT06206746
StatusRECRUITING
Start Date2024-03-25
Completion2029-09

Brief Summary

A Prospective, Multicenter, Randomized, Pivotal Study of the May Health System in Transvaginal Ablation of Ovarian Tissue under Ultrasound Guidance in Women with Infertility due to Polycystic Ovary Syndrome

Frequently Asked Questions

What is The REBALANCE Study - a Prospective, Multicenter, Randomized, Pivotal Study of the May Health System?

The REBALANCE Study - a Prospective, Multicenter, Randomized, Pivotal Study of the May Health System is a clinical trial registered under NCT06206746. Current status: RECRUITING.

What is the status of NCT06206746?

The current status of NCT06206746 (The REBALANCE Study - a Prospective, Multicenter, Randomized, Pivotal Study of the May Health System) is: RECRUITING.

When did The REBALANCE Study - a Prospective, Multicenter, Randomized, Pivotal Study of the May Health System start?

The REBALANCE Study - a Prospective, Multicenter, Randomized, Pivotal Study of the May Health System started on 2024-03-25.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑